Log in or Sign up for Free to view tailored content for your specialty!
Cornea/External Disease News
Association found between keratoconus, connective tissue hyperlaxity
A group of researchers found an association between keratoconus and connective tissue hyperlaxity in a large cohort of adolescents and young adults.
Spectral domain OCT used for assessment of corneal allogenic intrastromal ring segments
Keratoconus is a corneal ectatic disease that affects young individuals with significant visual symptoms.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Reverse four-throw pupilloplasty recommended for endothelial keratoplasty
SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, Priya Narang, MS, shares how to perform reverse four-throw pupilloplasty, which she helped develop.
Q&A: Gamers, digital screen users may be at greater risk for dry eye disease
Prolonged periods of gaming may contribute to the development of dry eye symptoms in young adults, according to a study presented at the 2023 EastWest Eye Care Conference.
VIDEO: Analysis explores real-world prescribing patterns for Dextenza
SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, Renee Bovelle, MD, discusses real-world insights on the use of Dextenza.
Harrow acquires NDA for Triesence
Harrow announced an early completed transfer of the new drug application for Triesence, a synthetic corticosteroid for treatment of several inflammatory ophthalmic conditions, including those not responsive to topical corticosteroids.
VIDEO: Understanding antibiotic resistance trends in eye infections important
SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, Penny A. Asbell, MD, FACS, MBA, overviews the ARMOR study and antibiotic resistance in eye infections.
BLOG: Sometimes brand matters: FDA forces recall of 27 generic artificial tears
Oh my. Another FDA recall of generic artificial tears hit the news during eyeball month.
FDA does not approve reproxalap for dry eye disease
The FDA issued a complete response letter regarding the new drug application for reproxalap for the treatment of dry eye disease, according to a press release from Aldeyra Therapeutics.
The magic of Miebo
There is simply no other way to put this: Miebo is magic.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read